About this document

Recombinant TSH Short Note 2025 by njagadish299 is a document available to read on EtoBox.

Recombinant human TSH (rhTSH, Thyrogen) is a biotechnologically produced glycoprotein used in managing well-differentiated thyroid cancer without inducing hypothyroidism. It is administered as a 0.9 mg intramuscular injection for two consecutive days, allowing for radioiodine diagnostic scanning and ablation while maintaining euthyroidism. Despite its advantages, including improved quality of life and equivalent efficacy to thyroid hormone withdrawal, rhTSH has limitations such as high cost and reduced effi

Author

njagadish299

Language

EN